This induces an immune suppressive phenotype in regulatory T cells, inhibits naïve CD8+ T cell activation, and prevents reactivation of exhausted CD8+ T cells, the cells that likely recognize tumor neoantigens [181]. This evidence concerns the gene CD8A and neoplasm.